You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline

You are reading 1 of 2 free-access articles allowed for 30 days

More females than males participating in BowelScreen

By Mindo - 25th Apr 2017 | 3 views

The report provides screening statistics for the first screening round of the programme’s operation (2012 – 2015).

During this period, BowelScreen invited 488,628 eligible people to participate in the programme with a total of 196,238 people screened and 521 cancers detected. This resulted in a screening uptake rate of 40.2 per cent and a cancer detection rate of 2.65 per 1,000 people screened.

Commenting on the first screening round of BowelScreen, Mr Charles O’Hanlon, Head of Screening at the National Screening Service, said: “During the first screening round, 521 cancers were detected, three out of four cases at an early stage with a corresponding high survival rate. Almost 13,000 adenomas were also removed during the first screening round. Adenomas are abnormal tissue growths that can become cancerous at a later stage. The removal of adenomas greatly reduces the possibility of subsequent cancer development, making BowelScreen a truly lifesaving programme.

“While there have been challenges in establishing a new population screening programme, this report demonstrates that BowelScreen is detecting and treating bowel cancers and pre-cancerous changes at an early stage. BowelScreen is saving lives. There is more we can do to learn and improve uptake rates as we move forward; however it is important to acknowledge the successes of the programme to date.”

The report reveals a low uptake of screening with just 40 per cent of eligible men and women participating in the programme. The uptake for women was higher than men (44.1 per cent compared to 36.4 per cent) yet the cancer detection rate among men was double that of women.

Prof Diarmuid O’Donoghue, Clinical Director of BowelScreen, said: “Low uptake of screening is worrying given bowel cancer is the second biggest cancer killer in this country. We are particularly concerned about men, given that the cancer detection rate among males is twice as high as it is for females. It is so important that the men of Ireland take control of their health and do the test. It is a very quick, easy-to-use test that can be carried out in the privacy of your own home. It takes just minutes and most results are normal.”

Prof O’Donoghue continued: “Going forward, BowelScreen is committed to making continual improvements in the quality of the programme and in increasing uptake. Although, there remain a number of years before the programme is fully embedded and delivering to its maximum potential, it is clear from the results above that a strong foundation has been created, upon which to build further success.”

Anyone aged 60 to 69 can register for BowelScreen online at or by calling the Freephone number 1800 45 45 55.

Brief overview of performance, from 22 October 2012 to 31 December 2015 (first screening round):

• BowelScreen invited 488,628 people for screening

• 196,238 people took up the invitation, resulting in a screening uptake rate of 40.2 per cent

• Uptake of screening for females was higher than in males (44.1 per cent compared to 36.4 per cent)

• 8,062 people attended for a colonoscopy

• 521 cancers were detected, giving an overall cancer detection rate of 2.65 per 1,000 people screened

• There were 355 colon cancers, 159 rectal cancers and seven cases of cancer where the site was unconfirmed

• Over 71 per cent of all cancers detected were stage I or II, meaning that disease was detected at an early stage and therefore, easier to treat

• In addition, approximately 13,000 pre-cancerous adenomas were removed.

Leave a Reply

Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read